Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
BBIO
BridgeBio Pharma
Last Price:
26.81
Seasonality Move:
21.04%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and BBIO is experiencing slight selling pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.1 | Sell |
20-day SMA: | 27.37 | Sell |
50-day SMA: | 26.49 | Buy |
200-day SMA: | 30.02 | Sell |
8-day EMA: | 27.05 | Sell |
20-day EMA: | 27.15 | Sell |
50-day EMA: | 26.81 | Buy |
200-day EMA: | 27.47 | Sell |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 49.11 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.77 - 29.09) | Sell |
Bollinger Bands (100): | (25.08 - 28.78) | Sell |
BridgeBio Pharma Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 26.83 while BBIO 8-day simple moving average is 27.10, which is a Sell signal.
- The stock price of BBIO is 26.83 while BridgeBio Pharma 20-day SMA is 27.37, which makes it a Sell.
- BridgeBio Pharma 50-day simple moving average is 26.49 while BBIO share price is 26.83, making it a Buy technically.
- BBIO stock price is 26.83 and BridgeBio Pharma 200-day simple moving average is 30.02, creating a Sell signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
42
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a Sell
The current BridgeBio Pharma [BBIO] share price is $26.83. The Score for BBIO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
5.04B
Price in USD:
26.83
Share Volume:
1.52M
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
21.62
Sell
42
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?
The BridgeBio Pharma stock price is 26.83 USD today. -
Will BBIO stock go up or go down?
BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is BridgeBio Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
- BridgeBio Pharma share price is 26.83 while BBIO 8-day exponential moving average is 27.05, which is a Sell signal.
- The stock price of BBIO is 26.83 while BridgeBio Pharma 20-day EMA is 27.15, which makes it a Sell.
- BridgeBio Pharma 50-day exponential moving average is 26.81 while BBIO share price is 26.83, making it a Buy technically.
- BBIO stock price is 26.83 and BridgeBio Pharma 200-day simple moving average is 27.47, creating a Sell signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $1.24 per share, and a decrease next year of $1.28 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
- BBIO Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting BridgeBio Pharma is a Buy
- BridgeBio Pharma Relative Strength Index (RSI) is 49.11, which suggest BridgeBio Pharma is oversold
- The Bollinger Bands (25) for BridgeBio Pharma is (24.77 - 29.09), which suggest BridgeBio Pharma is a Sell
- The Bollinger Bands (100) for BridgeBio Pharma is (25.08 - 28.78), which suggest BridgeBio Pharma is a Sell
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.